Dr. Lal Path Labs Ltd. Stock Forecast Period (n+1y) 28 Jun 2020


Stock Forecast


As of Fri Jun 26 2020 15:30:00 GMT+0000 (Coordinated Universal Time) shares of Dr. Lal Path Labs Ltd. 0.14 percentage change in price since the previous day's close. Around 121651 of 83341608 changed hand on the market. The Stock opened at 1556.25 with high and low of 1546.5 and 1575 respectively. The price/earnings ratio is: 56.91 and earning per share is 27.37. The stock quoted a 52 week high and low of 1031.45 and 1846 respectively.

BOSTON (AI Forecast Terminal) Sun, Jun 28, '20 AI Forecast today took the forecast actions: In the context of stock price realization of Dr. Lal Path Labs Ltd. is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+1y) for Dr. Lal Path Labs Ltd. as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of Dr. Lal Path Labs Ltd. as below:

Dr. Lal Path Labs Ltd. Credit Rating Overview


We rerate Dr. Lal Path Labs Ltd. because of deduct investments in insurance subsidiaries (as per paragraphs 41-43) and significant minority investments in financial institutions. We use econometric methods for period (n+1y) simulate with Bollinger Bands %B ANOVA. Reference code is: 3649. Beta DRL value REG 30 Rational Demand Factor LD 3998.106. Likewise, we do not consider factoring programs under sources of liquidity. Unlike asset-based lending (ABL) facilities, factoring is more of a sales transaction and not a loan. In addition, these transactions tend to be very short term. For this reason, we would not consider them a committed source of future liquidity over a 12-month period. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for Dr. Lal Path Labs Ltd. as below:
Frequently Asked QuestionsQ: What is Dr. Lal Path Labs Ltd. stock symbol?
A: Dr. Lal Path Labs Ltd. stock referred as NSE:LALPATHLAB
Q: What is Dr. Lal Path Labs Ltd. stock price?
A: On share of Dr. Lal Path Labs Ltd. stock can currently be purchased for approximately 1557.7
Q: Do analysts recommend investors buy shares of Dr. Lal Path Labs Ltd. ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for Dr. Lal Path Labs Ltd. at daily forecast section
Q: What is the earning per share of Dr. Lal Path Labs Ltd. ?
A: The earning per share of Dr. Lal Path Labs Ltd. is 27.37
Q: What is the market capitalization of Dr. Lal Path Labs Ltd. ?
A: The market capitalization of Dr. Lal Path Labs Ltd. is 128615800000
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com